Matches in Wikidata for { <http://www.wikidata.org/entity/Q84567412> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q84567412 description "artículu científicu espublizáu en xunetu de 2010" @default.
- Q84567412 description "im Juli 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q84567412 description "scientific article published on 14 July 2010" @default.
- Q84567412 description "wetenschappelijk artikel" @default.
- Q84567412 description "наукова стаття, опублікована в липні 2010" @default.
- Q84567412 name "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma" @default.
- Q84567412 name "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma" @default.
- Q84567412 type Item @default.
- Q84567412 label "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma" @default.
- Q84567412 label "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma" @default.
- Q84567412 prefLabel "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma" @default.
- Q84567412 prefLabel "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma" @default.
- Q84567412 P1433 Q84567412-63F62DA2-AC2E-44CF-A377-393DCA01BB0F @default.
- Q84567412 P1476 Q84567412-9206D69E-6F6D-493C-95E6-F2A54D083894 @default.
- Q84567412 P2093 Q84567412-14A6E1B8-BFEA-4566-8A2B-0651E26EA025 @default.
- Q84567412 P2093 Q84567412-3F2FBAE0-D445-495D-BC84-50A31403A1E7 @default.
- Q84567412 P2093 Q84567412-77A7DDA7-38E6-4920-95E8-AC740E0A01E4 @default.
- Q84567412 P2093 Q84567412-866909C6-5B48-46D1-958B-57D66CC520B1 @default.
- Q84567412 P2093 Q84567412-C646369A-3910-4F78-B806-5FCD43414804 @default.
- Q84567412 P2093 Q84567412-D329C4E5-B0E3-45B6-9F64-4AFFBE9E199F @default.
- Q84567412 P2093 Q84567412-D609AF0B-A5E5-49BE-B4C2-9AB2386F0BDE @default.
- Q84567412 P2093 Q84567412-EBAE0599-2747-4BD1-9934-0CD80F4ACDF9 @default.
- Q84567412 P304 Q84567412-1F8F7894-CAC1-47A7-A662-BBDBAAB5A94A @default.
- Q84567412 P31 Q84567412-6872B088-172C-4A2A-A096-B2062C1869D1 @default.
- Q84567412 P356 Q84567412-CF58DE6E-2608-4B68-B812-155C1FDE8B45 @default.
- Q84567412 P433 Q84567412-A8B036DC-22F1-4D74-A466-19F7E94671C2 @default.
- Q84567412 P478 Q84567412-2A604308-0A04-4E69-BF21-A7493E390943 @default.
- Q84567412 P50 Q84567412-56026FB0-B645-4F22-9AAD-B7CFA2422176 @default.
- Q84567412 P50 Q84567412-7EEC3C2E-1E0D-4A34-8CBD-3ED0B41ECC80 @default.
- Q84567412 P50 Q84567412-BAC48FDB-7F66-41E3-B9A5-54710CDA7315 @default.
- Q84567412 P577 Q84567412-7161512D-7BED-488E-B059-D5E520E435EE @default.
- Q84567412 P698 Q84567412-FA503E93-DB92-43DB-80B5-41F5DA4B740B @default.
- Q84567412 P921 Q84567412-8B9FFDFC-1EC9-4510-8F02-B318E9DB04F9 @default.
- Q84567412 P356 J.1365-2141.2010.08298.X @default.
- Q84567412 P698 20629661 @default.
- Q84567412 P1433 Q4970200 @default.
- Q84567412 P1476 "Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma" @default.
- Q84567412 P2093 "Anders Osterborg" @default.
- Q84567412 P2093 "Bo Bang" @default.
- Q84567412 P2093 "Francesco d'Amore" @default.
- Q84567412 P2093 "Franck Morschhauser" @default.
- Q84567412 P2093 "Hervé Tilly" @default.
- Q84567412 P2093 "Martin Dreyling" @default.
- Q84567412 P2093 "Martin Gramatzki" @default.
- Q84567412 P2093 "Thomas Relander" @default.
- Q84567412 P304 "565-573" @default.
- Q84567412 P31 Q13442814 @default.
- Q84567412 P356 "10.1111/J.1365-2141.2010.08298.X" @default.
- Q84567412 P433 "5" @default.
- Q84567412 P478 "150" @default.
- Q84567412 P50 Q42388605 @default.
- Q84567412 P50 Q63676594 @default.
- Q84567412 P50 Q87777731 @default.
- Q84567412 P577 "2010-07-14T00:00:00Z" @default.
- Q84567412 P698 "20629661" @default.
- Q84567412 P921 Q42824440 @default.